Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

T.; Grant

35 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Observational Study 16 Receptor Pharmacology 12 Toxicity 9 Animal Study 8 Addiction 7 Chronic Pain 6 Spirituality 5 Clinical Trial 5 Pharmacology 5 Adolescents 5 Cancer Patients 4 Safety 4

Journals

Scientific Reports 6 Journal of Psychopharmacology 4 Frontiers in Psychiatry 2 ACS Pharmacology & Translational Science 2 medRxiv 1 BMC Medicine 1 Clinical Neuropharmacology 1 Psychedelic Medicine 1

Publication history

Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot StudymedRxiv · 2026-07-13 The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer.BMC Medicine · 2026-07-05 An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive DisorderClinical Neuropharmacology · 2026-03-31 Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)Psychedelic Medicine · 2025-11-26 Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological RestorationUnknown journal · 2025-11-16 Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological RejuvenationUnknown journal · 2025-08-26 Toward Standardized Products Containing Biomass of Psilocybe Cubensis FungiJournal of AOAC International · 2025-08-12 Development and validation of an analytical method for the determination of select 4-position ring-substituted tryptamines in plasma by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2025-05-22 Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J micePsychopharmacology · 2025-05-15 Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorderPLoS ONE · 2025-05-06 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12 Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21 Physiological Effects of Psilocybin, Psilacetin, and DOI in RatsDrug and Alcohol Dependence · 2024-06-30 Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertensionFrontiers in Psychiatry · 2024-06-23 Psychedelic-like Activity of Norpsilocin AnaloguesACS Chemical Neuroscience · 2024-01-07 Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrestsFrontiers in Psychiatry · 2023-08-23 Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen useAddictive Behaviors Reports · 2023-08-10 Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in MiceACS Pharmacology & Translational Science · 2023-03-09 Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sampleScientific Reports · 2023-02-10 Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescentsScientific Reports · 2022-12-18 Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.ACS Pharmacology & Translational Science · 2022-11-01 Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.Journal of Psychopharmacology · 2022-10-30 Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.Scientific Reports · 2022-10-09 Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.ACS Omega · 2022-07-04 Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific Reports · 2022-06-21 Receptor binding profiles and behavioral effects of psilocybin analogsThe FASEB Journal · 2022-04-30 Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.Unknown journal · 2022-04-13 Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific Reports · 2022-04-06 Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.Scientific Reports · 2022-02-15 MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.Journal of Psychopharmacology · 2022-01-04 Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.Journal of Psychopharmacology · 2022-01-04 Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.Journal of Psychopharmacology · 2021-12-31 The Therapeutic Potential of Psilocybin.Unknown journal · 2021-05-14 Use of MDMA & Psilocybin in the Treatment of PTSDPDXScholar (Portland State University) · 2018-12-31 Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in Psychology · 2018-12-05

Author directory